Sustained Release Agent

Abstract Purpose: Effective mucosal delivery of drugs continues to pose a significant challenge owing to the formidable barrier presented by the...

Tamsulosin HCl is an αq-1 adrenergic receptor antagonist that is primarily used to treat benign prostatic hyperplasia (BPH), a disease...

Abstract The utilization of three-dimensional (3D) printing technology is prevalent in the fabrication of oral sustained release preparations; however, there...

Abstract The Theophylline and Salbutamol Bilayer Sustained-release Tablets (Yi Xi Qing®), prepared via wet granulation, discolor during long-term storage, and...

Abstract Food matrices are becoming increasingly complex with the impregnation of phytonutrients with health-beneficial pharmacological effects. Herein, we report the...

EUDRAGIT® polymers can be used individually or in combination to match virtually any target release profile including immediate, delayed, sustained,...

Following topical application of a dermatological product, the loss (by evaporation and/or absorption through the skin) of volatile excipients will...

Guanfacine (GFC) extended-release tablet (Intuniv®) is an effective non-stimulant medication prescribed for attention deficit hyperactivity disorder (ADHD), presenting limitations regarding...

OVERVIEW Hydrophilic matrices, particularly those formulated with hypromellose (HPMC), are essential for controlled drug release in pharmaceutical formulations. While HPMC...

Abstract Introduction: Microneedle patch is one of the fascinating drug delivery approaches that offers low invasiveness and a painless physical...